Exactech Inc. (NASDAQ:EXAC) Director James G. Binch sold 600 shares of the business’s stock in a transaction on Thursday, November 3rd. The stock was sold at an average price of $22.61, for a total value of $13,566.00. Following the completion of the transaction, the director now directly owns 5,682 shares in the company, valued at approximately $128,470.02. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Exactech Inc. (NASDAQ:EXAC) opened at 25.35 on Thursday. The stock’s 50 day moving average price is $26.03 and its 200 day moving average price is $26.11. Exactech Inc. has a 52 week low of $16.59 and a 52 week high of $28.66. The firm has a market cap of $358.68 million, a price-to-earnings ratio of 22.84 and a beta of 0.83.

Exactech (NASDAQ:EXAC) last released its quarterly earnings results on Monday, October 31st. The company reported $0.22 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.22. The business earned $59.90 million during the quarter, compared to analysts’ expectations of $58.69 million. Exactech had a return on equity of 6.89% and a net margin of 6.34%. The firm’s revenue for the quarter was up 6.6% compared to the same quarter last year. During the same period last year, the firm posted $0.20 EPS. On average, equities research analysts predict that Exactech Inc. will post $1.16 EPS for the current year.

Insider Buying and Selling by Quarter for Exactech (NASDAQ:EXAC)

Separately, Zacks Investment Research lowered Exactech from a “buy” rating to a “hold” rating in a research note on Tuesday, October 4th.

A number of hedge funds have recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP boosted its stake in Exactech by 13.1% in the second quarter. Dimensional Fund Advisors LP now owns 679,519 shares of the company’s stock valued at $18,170,000 after buying an additional 78,708 shares during the last quarter. Acadian Asset Management LLC boosted its stake in Exactech by 51.3% in the second quarter. Acadian Asset Management LLC now owns 507,639 shares of the company’s stock valued at $13,574,000 after buying an additional 172,172 shares during the last quarter. LSV Asset Management boosted its stake in Exactech by 7.5% in the second quarter. LSV Asset Management now owns 423,315 shares of the company’s stock valued at $11,319,000 after buying an additional 29,493 shares during the last quarter. BlackRock Institutional Trust Company N.A. boosted its stake in Exactech by 3.2% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 383,902 shares of the company’s stock valued at $10,377,000 after buying an additional 11,812 shares during the last quarter. Finally, Vanguard Group Inc. boosted its stake in Exactech by 6.8% in the second quarter. Vanguard Group Inc. now owns 381,928 shares of the company’s stock valued at $10,212,000 after buying an additional 24,355 shares during the last quarter. 64.72% of the stock is owned by institutional investors and hedge funds.

About Exactech

Exactech, Inc develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee implants, hip implants, biologics and spine, extremity implants and other products. Its other products segment includes surgical instruments, bone cement and other implant product lines.

5 Day Chart for NASDAQ:EXAC

Receive News & Stock Ratings for Exactech Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech Inc. and related stocks with our FREE daily email newsletter.